Log in

NASDAQ:CSIICardiovascular Systems Stock Price, Forecast & News

$31.25
+0.77 (+2.53 %)
(As of 08/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$30.28
Now: $31.25
$31.45
50-Day Range
$27.86
MA: $31.28
$34.45
52-Week Range
$26.00
Now: $31.25
$55.22
Volume343,195 shs
Average Volume335,848 shs
Market Capitalization$1.10 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.41
Cardiovascular Systems, Inc., a medical device company, develops, manufactures, and commercializes various devices to treat vascular and coronary diseases in the United States. The company offers peripheral arterial disease products, including Diamondback 360 Peripheral, Predator 360, Stealth 360 Peripheral Orbital Atherectomy System (OAS), Diamondback 360 60cm Peripheral OAS, Diamondback 360 Low Profile Peripheral, Diamondback 360 1.50 Peripheral, Diamondback 360 2.00 Peripheral, Diamondback 360 200cm Peripheral, and Diamondback 360 180cm Peripheral, which are catheter-based platforms for treating a range of plaque types in leg arteries above and below the knee, including calcified plaque, as well as address various limitations associated with surgical, catheter, and pharmacological treatment alternatives. It also provides Diamondback 360 Coronary OAS, an atherectomy device for the treatment of calcified coronary arteries. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in St. Paul, Minnesota.
Read More
Cardiovascular Systems logo

Beat the Market (BTM) Rank

Analyst Opinion: 4.5Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.75 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNASDAQ:CSII
CUSIP14161910
Phone651-259-1600

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$248.02 million
Cash Flow$0.09 per share
Book Value$4.25 per share

Profitability

Net Income$-250,000.00

Miscellaneous

Employees652
Market Cap$1.10 billion
Next Earnings Date8/4/2020 (Confirmed)
OptionableOptionable
$31.25
+0.77 (+2.53 %)
(As of 08/3/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CSII News and Ratings via Email

Sign-up to receive the latest news and ratings for CSII and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Cardiovascular Systems (NASDAQ:CSII) Frequently Asked Questions

How has Cardiovascular Systems' stock been impacted by COVID-19 (Coronavirus)?

Cardiovascular Systems' stock was trading at $36.32 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, CSII shares have decreased by 14.0% and is now trading at $31.25.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of Cardiovascular Systems?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardiovascular Systems in the last year. There are currently 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Cardiovascular Systems
.

When is Cardiovascular Systems' next earnings date?

Cardiovascular Systems is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020.
View our earnings forecast for Cardiovascular Systems
.

How were Cardiovascular Systems' earnings last quarter?

Cardiovascular Systems Inc (NASDAQ:CSII) released its quarterly earnings results on Tuesday, May, 5th. The medical device company reported ($0.08) earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of ($0.09) by $0.01. The medical device company had revenue of $61.18 million for the quarter, compared to analysts' expectations of $64 million. Cardiovascular Systems had a negative return on equity of 7.36% and a negative net margin of 4.04%.
View Cardiovascular Systems' earnings history
.

What price target have analysts set for CSII?

8 brokers have issued 1-year price targets for Cardiovascular Systems' stock. Their forecasts range from $40.00 to $58.00. On average, they expect Cardiovascular Systems' share price to reach $47.13 in the next twelve months. This suggests a possible upside of 50.8% from the stock's current price.
View analysts' price targets for Cardiovascular Systems
.

Has Cardiovascular Systems been receiving favorable news coverage?

Media coverage about CSII stock has been trending somewhat positive on Tuesday, according to InfoTrie Sentiment. InfoTrie identifies negative and positive media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Cardiovascular Systems earned a news sentiment score of 1.8 on InfoTrie's scale. They also assigned press coverage about the medical device company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the next several days.
View the latest news about Cardiovascular Systems
.

Who are some of Cardiovascular Systems' key competitors?

What other stocks do shareholders of Cardiovascular Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardiovascular Systems investors own include AbbVie (ABBV), Gilead Sciences (GILD), Netflix (NFLX), Adobe (ADBE), Advanced Micro Devices (AMD), Activision Blizzard (ATVI), Medtronic (MDT), Pfizer (PFE), Procter & Gamble (PG) and Target (TGT).

Who are Cardiovascular Systems' key executives?

Cardiovascular Systems' management team includes the following people:
  • Mr. Scott Raymond Ward M.S., MS, B.Sc., Chairman, Pres & CEO (Age 59)
  • Mr. Jeffrey S. Points, Chief Financial Officer (Age 42)
  • Ms. Rhonda J. Robb, Chief Operating Officer (Age 51)
  • Mr. Alexander Rosenstein, Gen. Counsel & Corp. Sec. (Age 47)
  • Ms. Laura J. Gillund, Chief Talent Officer (Age 58)

What is Cardiovascular Systems' stock symbol?

Cardiovascular Systems trades on the NASDAQ under the ticker symbol "CSII."

Who are Cardiovascular Systems' major shareholders?

Cardiovascular Systems' stock is owned by many different retail and institutional investors. Top institutional investors include Peregrine Capital Management LLC (1.43%), First Quadrant L P CA (0.18%), Cambiar Investors LLC (0.18%), Comerica Bank (0.16%), Assenagon Asset Management S.A. (0.15%) and First Trust Advisors LP (0.09%). Company insiders that own Cardiovascular Systems stock include Alexander Rosenstein, Jeffrey S Points, Martha Goldberg Aronson, Sandra Sedo and Scott R Ward.
View institutional ownership trends for Cardiovascular Systems
.

Which major investors are selling Cardiovascular Systems stock?

CSII stock was sold by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Falcon Point Capital LLC, First Trust Advisors LP, Dupont Capital Management Corp, Cambridge Investment Research Advisors Inc., MAI Capital Management, and UBS Group AG. Company insiders that have sold Cardiovascular Systems company stock in the last year include Alexander Rosenstein, and Sandra Sedo.
View insider buying and selling activity for Cardiovascular Systems
.

Which major investors are buying Cardiovascular Systems stock?

CSII stock was bought by a variety of institutional investors in the last quarter, including Peregrine Capital Management LLC, Cambiar Investors LLC, First Quadrant L P CA, Comerica Bank, Exchange Traded Concepts LLC, M&T Bank Corp, SG Americas Securities LLC, and Strs Ohio. Company insiders that have bought Cardiovascular Systems stock in the last two years include Martha Goldberg Aronson, and Scott R Ward.
View insider buying and selling activity for Cardiovascular Systems
.

How do I buy shares of Cardiovascular Systems?

Shares of CSII can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Cardiovascular Systems' stock price today?

One share of CSII stock can currently be purchased for approximately $31.25.

How big of a company is Cardiovascular Systems?

Cardiovascular Systems has a market capitalization of $1.10 billion and generates $248.02 million in revenue each year. The medical device company earns $-250,000.00 in net income (profit) each year or ($0.01) on an earnings per share basis. Cardiovascular Systems employs 652 workers across the globe.

What is Cardiovascular Systems' official website?

The official website for Cardiovascular Systems is www.csi360.com.

How can I contact Cardiovascular Systems?

Cardiovascular Systems' mailing address is 1225 OLD HWY 8 NW, ST. PAUL MN, 55112. The medical device company can be reached via phone at 651-259-1600 or via email at [email protected]

This page was last updated on 8/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.